PCOS in Women With Alström Syndrome

Polycystic ovary syndrome (PCOS) is a common condition in the general female population — and is particularly common in women with Alström Syndrome because of the underlying severe insulin resistance. PCOS in Alström affects fertility, menstrual cycles, skin and hair, and metabolic health. This article covers the picture of PCOS in Alström and how it's managed alongside other syndrome features.

PCOS involves a combination of features that can include:

• Irregular or absent menstrual cycles
• Excess androgen activity (hirsutism, acne, scalp hair thinning)
• Polycystic-appearing ovaries on ultrasound
• Insulin resistance
• Increased risk of type 2 diabetes
• Reduced fertility

In the general population, PCOS affects 5–10% of women. In women with Alström, it's substantially more common because the severe insulin resistance is a primary driver of PCOS pathophysiology.¹

Common PCOS-related findings in Alström include:

• Irregular menstruation — cycles longer than 35 days, infrequent periods, or absent periods
• Hirsutism — increased dark, coarse hair on the face, chest, abdomen, or back
• Acne — beyond what's typical for age
• Scalp hair thinning
• Difficulty losing weight
• Fertility difficulties
• Metabolic features — though these overlap heavily with Alström's underlying metabolic profile

PCOS is typically diagnosed using the Rotterdam criteria — two of the following three: 1. Irregular ovulation (irregular cycles) 2. Clinical or biochemical signs of excess androgens 3. Polycystic-appearing ovaries on ultrasound

Workup includes:

• Menstrual history
• Physical examination including hirsutism scoring
• Blood tests — testosterone, DHEA-S, LH, FSH, sex hormone binding globulin
• Pelvic ultrasound
• Glucose and insulin testing
• Lipids
• Thyroid function²

PCOS in Alström is managed alongside the broader metabolic care of the syndrome. Approaches include:

Lifestyle

• The same nutrition and activity principles that help diabetes and weight in Alström
• Reducing refined carbohydrates and sugary drinks
• Regular physical activity
• Weight management within what's biologically possible

Medications

Metformin — addresses insulin resistance directly; helps with menstrual regularity, fertility, and metabolic features

Combined oral contraceptive pills (COCs) — regulate cycles, reduce androgen-related symptoms (hirsutism, acne), provide endometrial protection. Considerations:

• Cardiovascular risk profile (some COCs less appropriate with cardiomyopathy)
• Liver function — some COCs may affect liver
• Diabetes-related considerations
• Discuss with the endocrinology and obstetrics team

Spironolactone — reduces androgen-related symptoms (hirsutism, acne); used selectively; avoid in pregnancy

GLP-1 agonists — addresses insulin resistance, supports weight reduction, increasingly used in PCOS

Topical and cosmetic approaches to hirsutism — eflornithine cream, laser hair reduction, electrolysis

Fertility

For women with Alström and PCOS who want to conceive:

• Pre-conception evaluation is essential (cardiac, metabolic, endocrine)
• Ovulation induction medications (clomiphene, letrozole) may be effective
• Metformin can support ovulation
• IVF in some cases
• Genetic counseling for the couple

We cover this in Pregnancy in Alström Syndrome and Family Planning Options.

PCOS in Alström adds to:

• Endometrial cancer risk if cycles are irregular over many years (regular cycles or progestin protection are important)
• Type 2 diabetes risk — already very high in Alström
• Cardiovascular risk — already elevated in Alström
• Mental health — body-image and identity issues are real

These warrant ongoing screening and proactive management.

• Type 2 Diabetes in Alström Syndrome
• Insulin Resistance in Alström Syndrome
• Hypogonadism and Puberty in Alström Syndrome
• Pregnancy in Alström Syndrome
• Family Planning Options When You're an Alström Carrier

April 30, 2026.